Perfusion ct vascular parameters do not correlate with immunohistochemically derived microvessel density count in colorectal tumors

Radiology

Volumn 268, Issue 2, 2013, Pages 400-410

  Dighe, Shwetal ^a   Blake, Helena ^a   Jeyadevan, Nelesh ^a   Castellano, Isabel ^b   Koh, Dow Mu ^b   Orton, Matthew ^c   Chandler, Ian ^d   Swift, Ian ^a   Brown, Gina ^b  

^a NATIONAL HEALTH SERVICE   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; ENDOGLIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; ARTIFACT REDUCTION; BLOOD FLOW; BLOOD VESSEL PARAMETERS; BLOOD VESSEL VOLUME; BLOOD VOLUME; CANCER STAGING; CAPILLARY DENSITY; CLINICAL ARTICLE; CLINICAL PROTOCOL; COLORECTAL TUMOR; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DISEASE ASSOCIATION; EXTRACELLULAR EXTRAVASCULAR SPACE VOLUME; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFORMED CONSENT; MALE; MEAN TRANSIT TIME; NEOVASCULARIZATION (PATHOLOGY); OBSERVER VARIATION; PERFUSION COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGIST; TUMOR INVASION; TUMOR VASCULARIZATION; VOLUME TRANSFER CONSTANT; WILCOXON SIGNED RANKS TEST;

AGED; AGED, 80 AND OVER; ARTIFACTS; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IOHEXOL; MALE; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROSPECTIVE STUDIES; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84880687694     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13112460     Document Type: Article

References (55)

1. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: A new significant and independent prognostic indicator in earlystage breast carcinoma. J Natl Cancer Inst 1992;84(24):1875-1887.
2. Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971;285(21):1182-1186.
3. Vermeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996;32A(14):2474-2484.
4. Li C, Gardy R, Seon BK, et al. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Br J Cancer 2003;88(9):1424-1431.
5. Vermeulen PB, Van den Eynden GG, Huget P, et al. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer. Br J Cancer 1999;79(2):316-322.
6. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N Engl J Med 1991;324(1):1-8.
7. Kaio E, Tanaka S, Kitadai Y, et al. Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma. Oncology 2003;64(1):61-73.
8. Furudoi A, Tanaka S, Haruma K, et al. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology 2002;62(2):157-166.
9. Miles KA. Measurement of tissue perfusion by dynamic computed tomography. Br J Radiol 1991;64(761):409-412.
10. Miles KA. Tumour angiogenesis and its relation to contrast enhancement on computed tomography: A review. Eur J Radiol 1999;30(3):198-205.
11. Miles KA, Griffiths MR. Perfusion CT: A worthwhile enhancement? Br J Radiol 2003;76(904):220-231.
12. Wang JH, Min PQ, Wang PJ, et al. Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. AJR Am J Roentgenol 2006;186(5):1423-1430.
13. Wang ZQ, Li JS, Lu GM, Zhang XH, Chen ZQ, Meng K. Correlation of CT enhancement, tumor angiogenesis and pathologic grading of pancreatic carcinoma. World J Gastroenterol 2003;9(9):2100-2104.
14. d'Assignies G, Couvelard A, Bahrami S, et al. Pancreatic endocrine tumors: Tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 2009;250(2):407-416.
15. Tateishi U, Nishihara H, Watanabe S, Morikawa T, Abe K, Miyasaka K. Tumor angiogenesis and dynamic CT in lung adenocarcinoma: Radiologic-pathologic correlation. J Comput Assist Tomogr 2001;25(1):23-27.
16. Goh V, Halligan S, Gartner L, Bassett P, Bartram CI. Quantitative colorectal cancer perfusion measurement by multidetector-row CT: Does greater tumour coverage improve measurement reproducibility? Br J Radiol 2006;79(943):578-583.
17. Goh V, Halligan S, Gharpuray A, Wellsted D, Sundin J, Bartram CI. Quantitative as sessment of colorectal cancer tumor vascular parameters by using perfusion CT: Influence of tumor region of interest. Radiology 2008;247(3):726-732.
18. Goh V, Halligan S, Hugill JA, Gartner L, Bartram CI. Quantitative colorectal cancer perfusion measurement using dynamic contrast-enhanced multidetector-row computed tomography: Effect of acquisition time and implications for protocols. J Comput Assist Tomogr 2005;29(1):59-63.
19. Goh V, Liaw J, Bartram CI, Halligan S. Effect of temporal interval between scan acquisitions on quantitative vascular parameters in colorectal cancer: Implications for helical volumetric perfusion CT techniques. AJR Am J Roentgenol 2008;191(6):W288-W292.
20. Goh V, Halligan S, Bartram CI. Quantitative tumor perfusion assessment with multidetector CT: Are measurements from two commercial software packages interchangeable? Radiology 2007;242(3):777-782.
21. Goh V, Halligan S, Daley F, Wellsted DM, Guenther T, Bartram CI. Colorectal tumor vascularity: Quantitative assessment with multidetector CT-do tumor perfusion measurements reflect angiogenesis? Radiology 2008;249(2):510-517.
22. Li ZP, Meng QF, Sun CH, et al. Tumor angiogenesis and dynamic CT in colorectal carcinoma: Radiologic-pathologic correlation. World J Gastroenterol 2005;11(9):1287-1291.
23. Feng ST, Sun CH, Li ZP, et al. Evaluation of microvessel density and vascular endothelial growth factor in colorectal carcinoma with 64-multidetector-row CT perfusion imaging [in Chinese]. Zhonghua Wei Chang Wai Ke Za Zhi 2008;11(6):537-541.
24. Newbold K, Castellano I, Charles-Edwards E, et al. An exploratory study into the role of dynamic contrast-enhanced magnetic resonance imaging or perfusion computed tomography for detection of intratumoral hypoxia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009;74(1):29-37.
25. Miles KA. Perfusion CT for the assessment of tumour vascularity: Which protocol? Br J Radiol 2003;76(Spec No 1):S36-S42.
26. 1990 Recommendations of the International Commission on Radiological Protection. Ann ICRP 1991;21(1-3):1-201.
27. St Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cereb Blood Flow Metab 1998;18(12):1365-1377.
28. Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, Tokunaga O. Endoglin (CD105) expression in angiogenesis of colon cancer: Analysis using tissue microarrays and comparison with other endothelial markers. Virchows Arch 2006;448(2):127-134.
29. Goh V, Halligan S, Hugill JA, Bartram CI. Quantitative assessment of tissue perfusion using MDCT: Comparison of colorectal cancer and skeletal muscle measurement reproducibility. AJR Am J Roentgenol 2006;187(1):164-169.
30. Dighe S, Castellano E, Blake H, et al. Perfusion CT to assess angiogenesis in colon cancer: Technical limitations and practical challenges. Br J Radiol 2012;85(1018):e814-e825.
31. Prall F, Gringmuth U, Nizze H, Barten M. Microvessel densities and microvascular architecture in colorectal carcinomas and their liver metastases: Significant correlation of high microvessel densities with better survival. Histopathology 2003;42(5):482-491.
32. Lackner C, Jukic Z, Tsybrovskyy O, et al. Prognostic relevance of tumour-associated macrophages and von Willebrand factorpositive microvessels in colorectal cancer. Virchows Arch 2004;445(2):160-167.
33. Sökmen S, Sarioglu S, Füzün M, Terzi C, Küpelioglu A, Aslan B. Prognostic significance of angiogenesis in rectal cancer: A morphometric investigation. Anticancer Res 2001;21(6B):4341-4348.
34. Choi HJ, Hyun MS, Jung GJ, Kim SS, Hong SH. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology 1998;55(6):575-581.
35. Kumar P, Wang JM, Bernabeu C. CD 105 and angiogenesis. J Pathol 1996;178(4):363-366.
36. Saad RS, Liu YL, Nathan G, Celebrezze J, Medich D, Silverman JF. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol 2004;17(2):197-203.
37. Endrich B, Vaupel P. The role of the microcirculation in the treatment of malignant tumours: Facts and fiction. In: Molls M, Vaupel P, eds. Blood perfusion and microenvironment of human tumours. Berlin, Germany: Springer, 1998; 19-39.
38. Yamamura T, Tsukikawa S, Yamada K, Yamaguchi S. Morphologic analysis of microvessels in colorectal tumors with respect to the formation of liver metastases. J Surg Oncol 2001;78(4):259-264.
39. DeVries AF, Kremser C, Hein PA, et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003;56(4):958-965.
40. Willett CG, Boucher Y, di Tomaso E, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 2004;10(2):145-147.
41. Meijerink MR, van Cruijsen H, Hoekman K, et al. The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients. Eur Radiol 2007;17(7):1700-1713.
42. Sahani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: Initial observations. Radiology 2005;234(3):785-792.
43. Koukourakis MI, Mavanis I, Kouklakis G, et al. Early antivascular effects of bevacizumab anti-VEGF monoclonal antibody on colorectal carcinomas assessed with functional CT imaging. Am J Clin Oncol 2007;30(3):315-318.
44. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL. Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995;177(3):275-283.
45. Vermeulen PB, Libura J, Libura M, et al. Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995;87(23):1797-1798; author reply 1801-1802.
46. Dhakal HP, Bassarova A, Naume B, et al. Breast carcinoma vascularity: A comparison of manual microvessel count and Chalkley count. Histol Histopathol 2009;24(8):1049-1059.
47. Axelsson K, Ljung BM, Moore DH 2nd, et al. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995;87(13):997-1008.
48. Erovic BM, Neuchrist C, Berger U, El-Rabadi K, Burian M. Quantitation of microvessel density in squamous cell carcinoma of the head and neck by computer-aided image analysis. Wien Klin Wochenschr 2005;117(1-2):53-57.
49. Gulubova M, Vlaykova T. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer. J Gastroenterol Hepatol 2009;24(7):1265-1275.
50. Yodavudh S, Tangjitgamol S, Puangsa-art S. Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer. J Med Assoc Thai 2008;91(5):723-732.
51. Galizia G, Lieto E, Ferraraccio F, et al. Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Clin Cancer Res 2004;10(10):3490-3499.
52. White JD, Hewett PW, Kosuge D, et al. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res 2002;62(6):1669-1675.
53. Fenjvesi A. Prognostic significance of tumorinduced angiogenesis in colorectal carcinoma [in Serbian]. Med Pregl 2003;56(5-6):263-268.
54. Takebayashi Y, Aklyama S, Yamada K, Akiba S, Aikou T. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer 1996;78(2):226-231.
55. Nakasaki T, Wada H, Shigemori C, et al. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 2002;69(4):247-254.